78. Hypopituitarism Clinical trials / Disease details

Clinical trials : 492 / Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00851942 (ClinicalTrials.gov)	September 2008	25/2/2009	Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test	Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test	Healthy;Adrenal Insufficiency;Hypopituitarism	Drug: Synacthen (Tetracosactrin)	Cardiff University	NULL	Completed	18 Years	80 Years	All	165	Phase 4	United Kingdom
2	EUCTR2007-000056-14-GB (EUCTR)	03/03/2008	04/01/2008	Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test Study	Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test Study	Normal, healthy volunteers to establish a reference range for the synacthen test, plus patients with hypoadrenalism/hypopituitarism MedDRA version: 9.1;Level: LLT;Classification code 10020936;Term: Hypoadrenalism MedDRA version: 9.1;Classification code 10021067;Term: Hypopituitarism	Trade Name: Synacthen	Cardiff University	NULL	Not Recruiting			Female: yes Male: yes	240	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes	United Kingdom
3	NCT00552487 (ClinicalTrials.gov)	October 2005	31/10/2007	Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis	Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis	Hashimoto Disease;Adrenal Insufficiency	Drug: synacthen	University of Wuerzburg	NULL	Completed	18 Years	N/A	Both	62	N/A	Germany